Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
26.30
-0.15 (-0.57%)
Jun 6, 2025, 4:08 PM HKT
-13.46%
Market Cap 11.69B
Revenue (ttm) 2.84B
Net Income (ttm) 443.04M
Shares Out 228.73M
EPS (ttm) 1.90
PE Ratio 13.83
Forward PE 9.93
Dividend 1.31 (4.98%)
Ex-Dividend Date Jun 17, 2025
Volume 288,740
Average Volume 728,714
Open 26.30
Previous Close 26.30
Day's Range 25.85 - 26.35
52-Week Range 21.70 - 42.95
Beta 0.48
RSI 54.75
Earnings Date Aug 15, 2025

About HKG:6826

Shanghai Haohai Biological Technology Co., Ltd. engages in the research, development, manufacture, and sale of biomedical materials in China, Europe, the United States, and internationally. It offers ophthalmology products consist of intraocular lens, medical sodium hyaluronate gel, and lubricant eye drop. The company also offers sodium hyaluronate injection, medical chitosan, medical sodium hyaluronate gel, anti-adhesion, and burn wound related products. In addition, it provides injectors, scalpels, suture needles and other products. Further, ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 2,156
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6826
Full Company Profile

Financial Performance

In 2024, HKG:6826's revenue was 2.68 billion, an increase of 1.70% compared to the previous year's 2.63 billion. Earnings were 420.45 million, an increase of 1.04%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.